Pyxis Oncology (PYXS) Debt Ratio (2021)
Pyxis Oncology's (PYXS) quarterly Debt Ratio came in at 0.07 in Q3 2021.
Powered by 
Analysis
Pyxis Oncology (PYXS) Debt Ratio (2021) Analysis & Trends
Pyxis Oncology (PYXS) has reported Debt Ratio for 1 consecutive years, with 0.07 the latest figure, recorded in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | - |
| 10 | Pyxis Oncology | 206.05 Mn | 173.06 Mn | - | - |